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Abstract
Objectives: Bioactive glasses which degrade in aqueous solutions may release bioactive ions such as fluoride (F-)
and support fluoride bioavailability in saliva. We investigated how these effects would be apparent in an in vivo
experimental trial after toothbrushing in comparison with sodium fluoride and amine fluoride.
Material and methods: In this single-center, randomized, parallel in vivo trial with a three strata block design, where
healthy subjects were randomly assigned into three groups. Each group brushed their teeth either with fluoridated
bioactive glass containing dentifrice, with a sodium fluoride (NaF) containing dentifrice or with amine fluoride (AmF)
containing toothpaste. Saliva was collected time intervals before, immediately after, 30, 60 and 120min after
toothbrushing. Fluoride concentration was determined in supernatant saliva and salivary sediment using a fluoride ion
selective electrode. The data were evaluated statistically using non-parametric tests.
Results: The increase of bioactive fluoride in supernatant saliva was higher after application of NaF or AmF compared
to fluoridated bioactive glass. In salivary sediment bioavailability of fluoride lasted longer after application of fluoridated
bioactive glass.
Conclusions: Toothbrushing with the fluoride containing bioactive glass dentifrices had positive effects on the
fluoride bioavailability within two hours. Fluoride containing bioactive glass represent a new area for investigation
in caries prophylaxis. The bioactive potential impact on the tooth remineralization should be examined further.
Trial registration: DRKS00016038.
Introduction
Fluoride is a key factor in both dental restorative and oral
healthcare products [1]. Numerous studies demonstrated
the effectiveness of fluoride in caries prevention and it is
now acknowledged that fluorides are the most effective
agents in caries prevention [1–4]. Fluorides enhance en-
amel surface remineralization, reducing its susceptibility
to demineralization [5–9], increase the resistance of the
apatite structure to acid attack and have antibacterial
properties [10]. Because dentifrices are widely used in oral
hygiene and caries prevention fluoride compounds are
added to the majority of them. Various fluoride com-
pounds are used in the different dentifrices of which the
most common in Europe are sodium fluoride (NaF) and
amine fluoride (AmF). The caries preventive effect of
fluoride is dependent on the fluoride bioavailability [11].
However, the bioavailability of fluoride after tooth
brushing is limited to a relatively short time interval. It
has been shown, that the salivary fluoride level is back to
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baseline after tooth brushing with conventional fluoride
containing dentifrices after 120 min [12–15]. On the
other hand, high fluoride doses are toxic and may result
in enamel disruption such as fluorosis [16–18]. It has
also been shown, that low doses of fluoride also enhance
enamel remineralization [9]. In the light of increasing
awareness in the population of the uptake of substances
which may have an impact on general and oral health it
is reasonable to reduce their uptake. Therefore, at-
tempts to increase the bioavailability of fluoride in the
oral cavity for a longer time period and to reduce the
fluoride dose at the same time have been undertaken.
Materials releasing calcium and fluoride ions for dentin
and enamel remineralization have been the topics of in-
tensive research [19]. A novel development is fluoride-
containing bioactive glass (F-bioactive glass) with a
relative low fluoride content compared to the conven-
tional fluoride containing dentifrices [20–22]. F-
bioactive glasses are amorphous silicate glasses, which
degrade in aqueous solutions [10, 23]. F−,bioactive glass
acts in aqueous solutions as a single source of both cal-
cium, phosphate and fluoride ions [19]. During selective
dissolution they may release bioactive ions such as
fluoride, strontium, or calcium [20, 24]. After hydroly-
sis, selective dissolution and the ion exchange of
F−bioactive glass in an aqueous environment apatite
can precipitate on biological surfaces and elicit an
interfacial biological response, such as bioactive fix-
ation, resulting in inhibiting further dissolution, and de-
crease complete resorption of the material [10].
Bioactive glasses are biocompatible and effective for
bone regeneration, bone engineering [25, 26] and for
the application in the oral cavity [27].
In medicine bioactive glasses have been developed for
the treatment of osteoporosis by substitution of calcium
with strontium [28] and for the application in ortho-
pedic surgery [25]. Strontium substituted bioactive glass
increases osteoblast proliferation and alkaline phosphat-
ase activity [28]. Fluoride-containing bioactive glasses
also impact osteoblast behavior and activity, enhance
and control of their proliferation, differentiation and
mineralization [10]. Bioactive glasses release bioactive
ions slowly which results in a prolonged biological effect
[25]. Because of the ability to release fluoride locally the
fluoride-containing bioactive glasses have already been
used in dentistry for various clinical applications e. g. for
the treatment of dentin hypersensitivity [10, 29]} and for
regeneration of osseous defects of the alveolar ridge [10,
22, 25, 30]. It has also been shown in in-vitro experi-
ments, that F-Bioactive glass induces fluor-hydroxyapatite
formation on enamel surfaces [21, 22, 31, 32]. Another
preliminary study demonstrated, that fluoride-containing
bioactive glass enhances enamel remineralization [21].
Bioactive glasses can bond to hard and soft tissues [10].
However, to our knowledge there are no comparative clin-
ical studies about the bioavailability of fluoride in oral cav-
ity after toothbrushing with a F-bioactive glass containing
dentifrice. It was therefore the aim of this in-vivo study to
investigate the dynamics of fluoride bioavailability in saliv-
ary compartments (supernatant and sediment) up to two
hours after standardized toothbrushing with F-bioactive
glass dentifrice and compare it with the fluoride bioavail-
ability in salivary compartments after application of denti-
frices containing NaF and AmF. The null hypothesis of
this study assumed that there are no differences in the
fluoride bioavailability between the different dentifrices in
supernatant saliva and salivary sediment.
Material and methods
Prior to the investigation the study has been approved by
the ethical committee (Nr. 170/2016) of Witten/Herdecke
University. This study has been registered in the German
Clinical Trials Register (# DRKS00016038). Registration
was done after the study has been conducted and the re-
sults suggested a publication and further continuation of
this research. The authors confirm that all ongoing and
related trials for this drug/intervention are registered. All
experiments were performed in accordance with relevant
guidelines, and informed written consent was obtained
from all participants.
Test subjects
Sixty subjects were asked to participate in this study.
Twelve refused to participate. Forty eight test subjects
aged between 20 and 28 years finally participated in this
parallel study (Fig. 1). All participants received written
instructions and a schedule. Participants were further
asked to avoid fluoride-rich food products such as tea,
fish and specified mineral water during the period but
had no restriction concerning drinking water. All test
subjects were residents in the area with ≈ 0.2 ppm fluor-
ide in the drinking water and normally used fluoride
containing dentifrices twice daily. They were randomly
and evenly distributed into three groups of eight male
and eight female subjects. All subjects received verbal
and written information about the investigation, as well
as written instructions regarding the schedule of the
study and proper tooth brushing methods. The inclusion
criteria were satisfactory oral and general health. The ex-
clusion criterion was the presence of active caries or
periodontal disease and systemic disease.
Materials
Three commercially available dentifrices with three differ-
ent fluoride formulations, F-bioactive glass (530 ppm) con-
taining dentifrice (BioMin F®; BIOMIN, London, UK), a
NaF (1450 ppm) containing dentifrice (Eurodont, MAXIM
Markenprodukte, Pulheim, Germany) and an AmF (1450
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ppm) containing toothpaste (Elmex, CP Gaba, Hamburg,
Germany) were used for toothbrushing in the present
study. The ingredients of the dentifrices are listed in
Table 1.
Study design and sample collection
The study was carried out as a parallel study and done at
2 .p.m. for each experiment. Prior to the experiments sal-
ivary flow rate was determined and only normal secretors
(0.25–1.0 g/min) were included. For standardization of
tooth brushing all test subjects brushed their teeth with
the same technique (Bass’ method of tooth brushing) [33].
Saliva was collected before (T0), immediately after (T1),
30 (T2), and 120 (T3) minutes after tooth brushing by
spitting into a plastic tube. Mouth rinsing was conducted
immediately after collection of sample T1 with 10ml tap
water within 10 s. After a washout period of two weeks
the groups repeated the brushing cycle. All experiments
were repeated three times. After collection saliva was cen-
trifuged (B Centrifuge, Beckman Coulter GmbH, Krefeld,
Germany) at a speed of 3024 x g for 10min. in micro-
centrifuge tubes to separate the cell-free supernatant saliva
and the cell containing sediment. Supernatant saliva and
salivary sediment were separated and frozen at − 800 until
fluoride determination.
Fluoride measurement
One ml supernatant saliva was taken and mixed with 1
ml of a TISAB II buffer solution (Thermo Electron, Bev-
erly, MA, USA). For equal fluoride ion distribution dur-
ing the measurement a magnetic stick stirrer (size 2
mm × 5mm) was used. The sediment was removed from
the centrifuge tube, dispersed in 250 ml TISAB II buffer
solution (Vortex-Genie 2 Scientific Industries, New
York, USA) in a new tube and weighted again. The
fluoride concentration was determined using a fluoride
Fig. 1 CONSORT flow chard depicting the three study arms
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ion selective electrode (96–09 Orion, Thermo Electron,
Beverly, MA, USA). The protocol of fluoride determin-
ation followed exactly as described by [15].
Statistics
A power calculation, based on the data of a previous
study [34], was performed with a power of 0.8 and α =
0.05 (mean 1 = 0.04; STD 1 = 0.084; mean 2 = 0.72; STD
2 = 0.88). The power analysis revealed a minimum sam-
ple size of 14 subjects. As program for the power ana-
lysis Axum 7 (Mathsoft, Cambridge, Massachusetts,
USA) was used.
From the repeated measurements of every subject the
mean value was calculated for each measurement and
used for statistical evaluation. The Shapiro-Wilk and
Kolmogorov-Smirnov test have been used for testing
the normality of the data. As these tests were negative
the results were evaluated statistically with the non-
parametric Mann-Whitney U test for independent vari-
ables and the Wilcoxon sign test for related variables.
Descriptive statistical data were presented as boxplot
graphics and tables. As statistic program served Graph-
pad Prism Ver. 7.0 (Graphpad, La Jolla, Ca, USA).
Results
Supernatant saliva
Comparison of the fluoride content in supernatant saliva
at the different collection times revealed statistically sig-
nificant differences between T0 and T1 for all fluoride
compounds. Fluoride content was still significantly higher
compared to T0 at T2 and T3 (Table 2 and Fig. 2). After
NaF application the fluoride content in the supernatant
saliva reached the baseline level after 120min and in AmF
after 30min (Table 2 and Fig. 2).
Between the different fluoride compounds statistically
significantly differences were found between F− bioactive
glass and NaF respectively AmF at T1, between F bio-
active glass and NaF at T2, between F− bioavtive glass
and NaF respectively AmF at T3. All results are summa-
rized in Table 3. All descriptive data of the distribution
of the measured values of supernatant saliva are summa-
rized in Table 4.
Salivary sediment
Comparison of the fluoride content in salivary sediment
at the different collection times revealed statistically sig-
nificant differences between T0 and T1 for all fluoride
compounds. Fluoride content was still significantly
higher compared to T0 at T2 in NaF and AmF. but not
for F-bioactive glass. Between T0 and T3 a significant
difference was found only for AmF (Table 5 and Fig. 3).
In salivary sediment the fluoride content was signifi-
cantly lower after AmF application than after F-bioactive
glass or NaF application (Table 6). At one collection
point T2 a significant difference between all fluorides
compounds was observed. The NaF content was higher
than with the other compounds (Table 6.). At collection
point T3 no difference in the fluoride content was ob-
served between F-bioactive glass and AmF (Table 5. and
Fig. 3). All descriptive data of the distribution of the
Table 1 Ingedients of the detifrices
Name Active fluoride component Other ingredients
BioMin F Bioactive glass Glycerin;
Silica;
PEG 400;
Fluoro Calcium Phpspho Slicate;
Sodium Lauryl Sulphate;
Titanium Dioxide;
Aroma;
Carbomer;
Potassium Acesulfame
eurodont NaF Aqua;
Hydrated silica;
Sorbitol;
Propylene Glycol;
NaF;
Potassium Nitrate;
Sodium Cq4–16 Olefin;
Sulfonate;
Aroma;
Cellulose gum;
Sodium Saccarin
Elmex AmF Aqua;
Hydrated silica;
Sorbitol;
Hydroxyaethylcellulose;
Olafluor;
Aroma;
Limonene;
Cl 77,891;
Sodium;
Saccarin;
Hydrochloric acid
Table 2 Fluoride content at different time points in supernatant
saliva
T0 - T1 T0 - T2 T0 - T3
F-bioactive glass p < 0.001 p < 0.001 p < 0.001
NaF p < 0.001 p < 0.001 p = 0.129
AmF p < 0.001 p = 0.687 p = 1.000
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measured values of salivary sediment are summarized in
Table 7.
Discussion
The most important unmet need in caries disease prophy-
laxes is the achievement of apatite demineralization-
remineralization balance. The protection of apatite from
destruction can be achieved by the application of the pro-
tective substances that can slow or prevent tooth
demineralization. Force the remineralization or decrease
the development of the oral biofilm with the pathogenic
microorganisms. Which produce acid for the HAP de-
struction. Fluoride has all three of these characteristics:
stabilizing the demineralization-remineralization balance
[35, 36]. decreasing the development of the plaque [37]
and has antibacterial activity against streptococci mutans
[38]. which are accumulated in the oral biofilm [12].
Fluoride occurs in the oral cavity in two forms: active
(free fluoride ions) and inactive (bound or complexed
fluoride). depending on the pH. ionic strength and protein
Fig. 2 Boxplot graphics of the data distribution of the fluoride content in supernatant saliva after application of different fluoride compounds at
different collection times (y axis log scale)
Table 3 Differences between fluoride content in different
fluoride compounds at different collection times in supernatant
saliva
T0
F-bioactive glass AmF
NaF p < 0.001 p < 0.001
AmF p = 0.217
T1
F-bioactive glass AmF
NaF p < 0.001 p = 0.024
AmF p < 0.001
T2
F-bioactive glass AmF
NaF p < 0.001 p < 0.001
AmF p = 0.246
T3
F-bioactive glass AmF
NaF p < 0.001 p < 0.001
AmF p = 0.036
Table 4 Descriptive data of the measured values of fluoride
content in supernatant saliva in ppm
Median Minimum Maximum
T0
F-bioactive glass 0.024 0.01 0.11
NaF 0.07 0.01 12.27
AmF 0.04 0.01 2.51
T1
F-bioactive glass 23.05 12.00 33.73
NaF 122.83 30.70 234.67
AmF 109.00 66.33 168.33
T2
F-bioactive glass 0.08 0.03 0.41
NaF 0.48 0.10 14.50
AmF 0.34 0.09 6.32
T3
F-bioactive glass 0.02 0.01 0.07
NaF 0.09 0.03 0.26
AmF 0.07 0.02 0.76
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concentration; these two forms are often easily inter-
changeable by simply changing the pH [39]. The active
form of fluoride determines its bioavailability.
After application of fluoride containing dentifrices the
fluoride bioavailability in saliva increases dramatically for
a short time interval and then declines reaching the
baseline level after about 120 min [13, 15, 34, 40–42].
Several studies demonstrated that the content of fluoride
in supernatant saliva is much lower than in the salivary
sediment [14, 15]. NaF dissolves in saliva quickly and
has a rapid clearance because it is swallowed with saliva.
The amino group of AmF is supposed to adhere to or-
ganic surfaces and remain longer in the oral cavity. Not
much is known about the bioactive potential of the F-
bioactive glass in the oral cavity [10]. So far there is no
in-vivo study about the distribution and retention of
fluoride in supernatant saliva and salivary sediment for
F-bioactive glass containing dentifrice.
The primary outcome in the present study was the ad-
justed fluoride bioavailability dynamic in supernatant
saliva and salivary sediment during two hours after stan-
dardised toothbrushing. With the fluoride-containing
bioactive glasses dentifrice compared to the dentifrice
with the other fluoride formulations followed by a one-
week washout period.
The results of the present study showed. That there is a
difference between the fluoride bioavailability in super-
natant saliva and salivary sediment for all three dentifrices
with the different fluoride compounds. Therefore the null
hypothesis has been rejected. In supernatant saliva the
fluoride bioavailability after brushing with the NaF contain-
ing dentifrice was back to baseline after 120min whereas
after AmF containing toothpaste application it was back to
base line as soon as 30min after application. Fluoride bio-
availability in the supernatant saliva after F-bioactive glass
dentifrice application remained significantly higher than the
Table 5 Fluoride content at different time points in salivary
sediment
T0 - T1 T0 - T2 T0 - T3
F-bioactive glass p < 0.001 p = 0.303 p = 0.246
NaF p < 0.001 p < 0.001 p = 0.012
AmF p < 0.001 p < 0.001 p < 0.001
Fig. 3 Boxplot graphics of the data distribution of the fluoride content in salivary sediment after application of different fluoride compounds at
different collection times (y axis log scale)
Table 6 Differences between fluoride content in different
fluoride compounds at different collection times in sliavary
sediment
T0
F-bioactive glass AmF
NaF p = 0.247 p < 0.001
AmF p < 0.001
T1
F-bioactive glass AmF
NaF p = 0.265 p < 0.001
AmF p < 0.001
T2
F-bioactive glass AmF
NaF p < 0.001 p < 0.001
AmF p < 0.001
T3
F-bioactive glass AmF
NaF p < 0.001 p < 0.001
AmF p = 0.002
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baseline until 120min after application. Therefore. the ori-
ginal assumption. That F-bioactive glass may release fluor-
ide for a prolonged time interval than two hours after
toothbrushing might be accepted. For salivary sediment
completely. Different results were obtained. Like super-
natant saliva in salivary sediment the fluoride bioavailabil-
ity was back to the baseline level after 120min after
application of a NaF containing dentifrice. However. after
application of an AmF containing dentifrice the fluoride
bioavailability remained significantly higher compared to
the baseline until 120min after application. After applica-
tion of a F-bioactive glass dentifrice the fluoride bioavail-
ability was back to baseline as soon as 30min after
application. It may be speculated that the fact that the
fluoride is bound the bioactive glass and not to the pro-
teins of the sediment is the reason for the quick clearance
from salivary sediment. With respect to NaF and AmF the
results confirm previous studies about the clearance of
fluoride in whole saliva [43–46]. Only few studies exist
about the fluoride bioavailability after application of NaF
or AmF in salivary sediment [14, 15]. It has been discussed
whether salivary sediment acts as fluoride reservoir releas-
ing fluoride slowly for a prolonged time. Fluoride bioavail-
ability varies also in the different oral niches where
different surfaces influence the fluoride bioavailability [12,
47, 48]. Other studies investigated the fluoride bioavail-
ability in dental plaque and reported elevated fluoride
concentrations after toothbrushing [44, 46].
However, in contrast to both other applied fluoride
compounds the fluoride bioavailability in salivary sedi-
ment could not be proven after application of F-bioactive
glass. Therefore, it might be assumed. That the mecha-
nisms for liberating bioavailable fluoride for NaF. AmF
and fluoride-containing bioactive glass from salivary
sediment might be completely different. Whether this
has an influence on the remineralization of the enamel
surface has to be elucidated in further experimental
and clinical studies.
Conclusions
Within the limits of this investigation it may be con-
cluded that administration of F-bioactive glass with 530
ppm F− results in a similar fluoride bioavailability in
supernatant saliva as administration of NaF or AmF with
1450 ppm F−.
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